Alnylam Pharmaceuticals Inc (ALNY) — Cash Flow Reinvestment Rate
Alnylam Pharmaceuticals Inc (ALNY) has a Cash Flow Reinvestment Rate of 0.23x as of December 2025, reinvesting $37.17 Million (capex $23.29 Million plus investments $-13.87 Million) from operating cash flow of $163.56 Million. Check Alnylam Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Alnylam Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Alnylam Pharmaceuticals Inc across 4 annual periods. Explore Alnylam Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Alnylam Pharmaceuticals Inc (2007–2025)
Year-by-year capital reinvestment analysis for Alnylam Pharmaceuticals Inc. For live market cap and broader valuation context, see Alnylam Pharmaceuticals Inc (ALNY) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.06x | $555.87 Million | $524.08 Million | $58.70 Million | ▼ -62.9% |
| 2023 | 2.86x | $297.82 Million | $104.16 Million | $62.21 Million | ▲ +1639.7% |
| 2008 | 0.16x | $10.76 Million | $65.49 Million | $10.76 Million | ▲ +314.7% |
| 2007 | 0.04x | $7.79 Million | $196.52 Million | $7.79 Million | — |